• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. AVANTAGE E1 INLAY S58 / 28; HIP PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. AVANTAGE E1 INLAY S58 / 28; HIP PROSTHESIS Back to Search Results
Model Number N/A
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Unspecified Infection (1930); Insufficient Information (4580)
Event Date 06/20/2023
Event Type  Injury  
Event Description
It was reported that patient underwent hip prostheses implantation.Subsequently, nine (9) months later, revision surgery was performed to remove the spacer and to put revision prosthesis in situ.Due diligence is in progress for this complaint; to date no additional information or product has been received.
 
Manufacturer Narrative
(b)(4).G-2 foreign: australia.D10: avantage cemented cup s58, item# p0463058, lot# 1626979.Zb 12/14 cocr hd 28mm x +3.5, item# 802202803, lot 3047459.Cpt 12/14 size 3 cocr ext, item# 00-8114-003-10, lot 65270823.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Manufacturer Narrative
(b)(4).Upon reassessment of the reported event, it was determined a medwatch report should not have been filed.The reported event of unspecified infection occurred >90 days post implantation.During the investigation process a review of the sterile certifications were reviewed and found to be conforming with no applicable deviations.Devices were verified to have gone through acceptable sterilization process following iso/aami/astm & eu published guidelines.There are multiple factors that may contribute to an infection that are outside the control of zimmer biomet, such as external factors, i.E.Hospital/surgical environment, provider related risk factors, and/or patient comorbidities/risk factors.As there are no indications of a product or process issues identified affecting implant safety or effectiveness, therefore implanted products are not identified as the source or contributing to the reported infection given this information, this medwatch will be voided.
 
Event Description
Upon reassessment of the reported event, it was determined a medwatch report should not have been filed.The reported event of unspecified infection occurred >90 days post implantation.During the investigation process a review of the sterile certifications were reviewed and found to be conforming with no applicable deviations.Devices were verified to have gone through acceptable sterilization process following iso/aami/astm & eu published guidelines.There are multiple factors that may contribute to an infection that are outside the control of zimmer biomet, such as external factors, i.E.Hospital/surgical environment, provider related risk factors, and/or patient comorbidities/risk factors.As there are no indications of a product or process issues identified affecting implant safety or effectiveness, therefore implanted products are not identified as the source or contributing to the reported infection given this information, this medwatch will be voided.
 
Event Description
It was reported that patient underwent hip prostheses implantation.Subsequently, nine (9) months later, due to infection, revision surgery was performed to remove the spacer and to put revision prosthesis in situ.Attempts have been made and no further information has been provided.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional and/or corrected information.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVANTAGE E1 INLAY S58 / 28
Type of Device
HIP PROSTHESIS
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key17324001
MDR Text Key319027139
Report Number3006946279-2023-00065
Device Sequence Number1
Product Code KWA
UDI-Device Identifier00887868525001
UDI-Public(01)00887868525001(17)250705(10)0001490803
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberN/A
Device Catalogue NumberP0561E58
Device Lot Number0001490803
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/20/2023
Initial Date FDA Received07/14/2023
Supplement Dates Manufacturer Received08/02/2023
09/18/2023
Supplement Dates FDA Received08/25/2023
09/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexPrefer Not To Disclose
-
-